Yoshimura et al., 2023 - Google Patents
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasisYoshimura et al., 2023
View HTML- Document ID
- 11900303011199577940
- Author
- Yoshimura T
- Li C
- Wang Y
- Matsukawa A
- Publication year
- Publication venue
- Cellular & Molecular Immunology
External Links
Snippet
Breast cancer is the most prevalent cancer worldwide, and metastasis is the leading cause of death in cancer patients. Human monocyte chemoattractant protein-1 (MCP-1/CCL2) was isolated from the culture supernatants of not only mitogen-activated peripheral blood …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yoshimura et al. | The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis | |
Zhou et al. | Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis | |
Mou et al. | MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8 | |
Deng et al. | CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer | |
Wang et al. | PDCD4 deficiency aggravated colitis and colitis-associated colorectal cancer via promoting IL-6/STAT3 pathway in mice | |
US11344601B2 (en) | Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor | |
CN113215158B (en) | circPTEN1 for tumor treatment target and diagnosis biomarker and application thereof | |
Takahashi et al. | Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model | |
Zhu et al. | IRX5 promotes colorectal cancer metastasis by negatively regulating the core components of the RHOA pathway | |
Ryu et al. | Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine | |
JP2022505327A (en) | Composition for treating gastric cancer containing SYT11 inhibitor as an active ingredient | |
Wu et al. | The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages | |
Zhao et al. | A novel microRNA-182/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer | |
Xu et al. | DLEU2: a meaningful long noncoding RNA in oncogenesis | |
Xu et al. | Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast | |
Jiang et al. | TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway | |
JP2021113824A (en) | Scirrhous gastric cancer therapeutic agent, and gastric cancer prognosis prediction method | |
Hu et al. | m6A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6A‐EGFR/STAT3 axis and EMT | |
CN113832226B (en) | Method for researching correlation between GNL3 and liver cancer development and application of GNL3 as liver tumor stem cell and liver cancer marker | |
Xie et al. | Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis | |
WO2020040186A1 (en) | Agent using hsp47 inhibitor to suppress metastasis | |
Zhao et al. | H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR‐141/ICAM‐1 and miR‐139/CXCR4 Axes | |
JP7510144B2 (en) | Anticancer drugs and their uses | |
Kzhyshkowska et al. | Targeting of TAMs: can we be more clever than cancer cells? | |
Zhu et al. | Retracted: Bladder cancer‐associated transcript 2 contributes to nephroblastoma progression |